The thing is: the "FDA red tape" is justified but expensive, and the market is so small that it takes a long time to recover the initial outlays. One thing tha

The thing is: the "FDA red tape" is justified but expensive, and the market is so small that it takes a long time to recover the initial outlays. One thing that could be done is subsidies for FDA-related expenses for orphan drugs.